| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 4,389,946 | 2,950,567 | 2,236,859 | | Cost of Revenue | 2,768,752 | 1,745,843 | 1,164,112 | | | Gross Profit | 1,621,194 | 1,204,724 | 1,072,747 | | | Operating Expenses | | Research Development | 12,789 | 9,728 | 26,112 | | Selling General and Administrative | 688,424 | 445,658 | 303,403 | | Non Recurring | 207,467 | 190,402 | 40,297 | | Others | 548,851 | 228,926 | 128,838 | | | | Total Operating Expenses | 1,457,531 | 874,714 | 498,650 | | | | Operating Income or Loss | 163,663 | 330,010 | 574,097 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 30,137 | 53,077 | 66,002 | | Earnings Before Interest And Taxes | 193,800 | 383,087 | 640,099 | | Interest Expense | 421,825 | 244,808 | 135,853 | | Income Before Tax | (228,025) | 138,279 | 504,246 | | Income Tax Expense | (59,700) | 21,591 | 62,243 | | Minority Interest | 4,767 |
-
|
-
| | | | Net Income From Continuing Ops | (163,558) | 116,688 | 442,003 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (163,558) | 116,688 | 442,003 | | Preferred Stock And Other Adjustments | (25,206) |
-
|
-
| | | Net Income Applicable To Common Shares | ($188,764) | $116,688 | $442,003 |
|
1.48% Nasdaq 
Income Statement
